Founder's key components: GLS, GLS2, SLC1A5, GLUD1 Founder's description: "Conversion of glutamine into TCA-cycle intermediates for energy production and biosynthesis."
DRY status
DRY: none located. Query run: the single Russian plus English Filonov-tradition query listed under node 28. No DRY-modality glutamine, glutaminase or renal-gluconeogenesis measurement was located. Glutamine-specific DRY queries and the nine non-English channels could not be run (search budget exhausted). Recorded NOT RUN.
The honest check the brief asked for
The brief asked whether human glutaminolysis under fasting is thin outside cancer-cell work. Answer, measured: it is thin AS GLUTAMINOLYSIS and substantial AS GLUTAMINE FLUX, and those are not the same claim. Human fasting-relevant glutamine data are real, quantitative and decades deep. All of it is about glutamine as a GLUCONEOGENIC SUBSTRATE (kidney and liver) and about glutamine SYNTHESIS in muscle. None of it is about GLS-driven anaplerosis in the sense the node name carries from cancer biology. No human fasting study measuring GLS, GLS2, SLC1A5 or GLUD1 expression or activity was located. The node's own named components have zero located human fasting measurement. Any row at the component level would be M.
Disconfirming, nulls and conflicts first
D29.1. Circulating glutamine AND glutamate DECREASE during a 10-day fast. Steinhauser ML, Olenchock BA, O'Keefe J, Lun M, Pierce KA, Lee H, Pantano L, Klibanski A, Shulman GI, Clish CB, Fazeli PK. "The circulating metabolome of human starvation." JCI Insight 2018;3(16):e121434. DOI 10.1172/jci.insight.121434. Design: 0-calorie, medically supervised inpatient fast of 10 days. Water ad libitum, daily multivitamin, 20 mEq potassium chloride, 200 mg allopurinol. 12 subjects enrolled, 8 completed the full 10 days. Weight loss 7.0% to 11.7% of initial body weight. Plasma at prebaseline, day 0, days 1, 2, 3, 5, 7, 9, 10, and after refeeding. Measured: glutamine and glutamate DECREASED with fasting. Alanine decreased, which the authors attribute to hepatic uptake for gluconeogenesis. 351 metabolites deviated from baseline (adjusted P < 0.05); 292 also had a log fold change greater than 0.5. Modality PF. Tier H3 (single-arm pre/post). Grade B+. No magnitudes or time points for glutamine or glutamate are in the text served. See retrieval debt R29.1. This cuts directly against any reading that fasting drives glutaminolysis up in humans at the circulating level.
D29.2. Higher glutamine appearance does not mean faster glutamine disposal. Nurjhan 1995 (full citation in 29-R1): glutamine plasma CLEARANCE 9.3 +/- 0.8 ml/kg/min versus alanine 14.7 +/- 1.3 ml/kg/min, P < 0.001, even though glutamine APPEARANCE was the higher of the two. Clearance and appearance move in opposite directions here. A row written only off appearance would mislead.
D29.3. The liver arm of glutaminolysis is weak in humans. The kidney carries it. Holecek M. "Origin and Roles of Alanine and Glutamine in Gluconeogenesis in the Liver, Kidneys, and Small Intestine under Physiological and Pathological Conditions." Int J Mol Sci 2024;25(13):7037. DOI 10.3390/ijms25137037. States: hepatic glutamine net uptake is MINIMAL, while alanine accounts for about 50% of total hepatic amino acid uptake. Tier H3 (review of human balance data). Grade B.
D29.4. UNRESOLVED CONFLICT inside the source: human renal lactate balance during fasting. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE. "Renal glucose production and utilization: new aspects in humans." Diabetologia 1997;40:749 to 757. That review states human net renal lactate balance data are inconsistent, ranging from virtually zero to significant net uptake after a 60-hour fast, and gives no quantitative conversion values. Reported unresolved. Same review: the glycerol 10% contribution to renal gluconeogenesis comes from a CANINE study, not a human one. Human data show net renal glycerol uptake with no quantitative conversion value. That is an A1 fact standing in for a human one in the secondary literature, and it is flagged here so it does not propagate.
D29.5. The classic 5 to 6 week starvation catheterization study contains NO glutamine number. Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr. J Clin Invest 1969;48(3):574 to 583. DOI 10.1172/JCI106016. It measured only total alpha-amino nitrogen, which the paper itself calls "a gross representation of all the amino acids," and states that individual amino acid fluctuations were "a topic currently under study." Values: arterial alpha-amino nitrogen 3.61 +/- 0.19 mmol/L; splanchnic arteriovenous difference 0.14 +/- 0.045; renal arteriovenous difference 0.16 +/- 0.04. Anyone citing Owen 1969 for a glutamine claim is citing something that is not in it.
Graded rows
29-R1. Glutamine is a major gluconeogenic precursor in postabsorptive humans, comparable to alanine in carbon transfer to glucose and larger in appearance and in release from protein. Grade B+, tier H3, modality: none of the nine, postabsorptive overnight state. Nurjhan N, Bucci A, Perriello G, Stumvoll M, Dailey G, Bier DM, Toft I, Jenssen TG, Gerich JE. "Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man." J Clin Invest 1995;95(1):272 to 277. DOI 10.1172/JCI117651. PMID 7814625. Postabsorptive normal volunteers, isotopic steady state with [U-14C]glutamine, [3-13C]alanine, [2H5]phenylalanine and [6-3H]glucose, plus the forearm balance technique. Mean +/- SE:
| Measure | Glutamine | Alanine | P |
|---|---|---|---|
| Plasma appearance, micromol/kg/min | 5.76 +/- 0.26 | 4.40 +/- 0.33 | < 0.001 |
| Plasma clearance, ml/kg/min | 9.3 +/- 0.8 | 14.7 +/- 1.3 | < 0.001 |
| Appearance from protein release, micromol/kg/min | 2.45 +/- 0.25 | 1.16 +/- 0.12 | < 0.001 |
| Carbon transfer to glucose, atoms/kg/min | 3.53 +/- 0.24 | 3.47 +/- 0.32 | comparable |
| Glucose carbon from protein-derived precursor, atoms/kg/min | 1.48 +/- 0.15 | 0.88 +/- 0.09 | < 0.01 |
| Forearm muscle release, micromol/100 ml/min | 0.88 +/- 0.05 | 0.48 +/- 0.05 | < 0.01 |
Subject number and fasting duration are NOT stated in the excerpt opened. See retrieval debt R29.2. Modality honesty: this is the overnight postabsorptive state. It is not TRE, PF or any other label in the brief.
29-R2. Almost all systemic glutamine gluconeogenesis in overnight-fasted humans happens in the kidney, and glutamine supplies 15 to 20% of renal glucose production. Grade B+, tier H3, modality: overnight postabsorptive, plus one 5 to 6 week PF row. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE. Diabetologia 1997;40:749 to 757.
- Glutamine accounts for about 60% of amino acids taken up by human kidneys.
- Almost 80% of systemic glutamine gluconeogenesis occurs in the kidney in overnight-fasted humans.
- Renal glutamine gluconeogenesis accounts for 15 to 20% of renal glucose production.
- Glutamine and alanine each contribute approximately equal amounts of gluconeogenic glucose in overnight-fasted humans. Alanine is NOT converted to glucose by the kidney.
- Renal glucose release is about 25% of systemic glucose production postabsorptive. Essentially all renal glucose release is gluconeogenic, so the kidney's gluconeogenic contribution is about half the liver's.
- PROLONGED FASTING row, modality PF: Owen et al., 5 to 6 weeks fasted, n = 11, net renal glucose output contributed "nearly 50%" of systemic glucose appearance. No rate value given. This agrees with 28-R6.
- Postabsorptive turnover table, n = 10: systemic glucose turnover 11.4, renal glucose release 3.2 (28% of turnover), renal glucose uptake 2.3 (20%), renal net balance -0.9.
TWO FLAGS ON THAT TABLE, neither of which this file silently fixes. (a) UNIT AS PRINTED: the retrieved text prints these as mmol/kg/min. A systemic glucose turnover of 11.4 mmol/kg/min is not physiologic and the figure is almost certainly micromol/kg/min. I did not open the original table, so the unit is reported exactly as served and flagged. See retrieval debt R29.3. (b) INTERNAL DISCREPANCY: the table's 3.2 of 11.4 is 28%, while the same review's body text says about 25%. Named, not reconciled. Other human numbers in the same review, recorded because they bound the node: epinephrine infusion (saline n = 4, epinephrine n = 6) raised systemic glucose production about 60%, hepatic release about 50%, renal release about 100%. Insulin repletion in IDDM lowered renal glucose production about 50% versus about 80% for hepatic. A net renal glucose release of "up to 880 mmol/min" is reported for severe chronic respiratory acidosis; the source prints that value with those units and it is very likely a typographical error in the source. Flagged, not used.
29-R3. Glutamine appearance in healthy postabsorptive humans is about 325 micromol/kg/h, about 80 g/day. Grade B, tier H3, modality: overnight postabsorptive. Holecek M. Int J Mol Sci 2024;25(13):7037. DOI 10.3390/ijms25137037.
- Glutamine appearance about 325 micromol/kg/h (about 80 g/day); alanine about 200 micromol/kg/h (about 30 g/day). Attributed to Darmaun, Matthews and Bier (1988). That primary paper was not opened.
- Plasma alanine about 0.3 mM, glutamine about 0.6 mM. No primary study given for these.
- Kidneys account for 15 to 40% of endogenous glucose production in postabsorptive humans and the share rises during starvation and acidosis. Qualitative on the starvation rise, with no numeric values.
- Glutamine supplies up to 20% of renal gluconeogenesis postabsorptive.
Animal rows in the same review, tier A1, recorded for direction only: rat metabolic acidosis raised hindquarter glutamine release from 79 +/- 14 to 391 +/- 59 nmol/min/100 g while alanine release fell from 203 +/- 12 to 37 +/- 13 nmol/min/100 g. Those are acidosis, not fasting.
29-R4. Direction note: in muscle, fasting is associated with glutamine SYNTHESIS, not glutamine consumption. Located, NOT opened. Two sources were located and could not be opened. No numbers are claimed from either. Titles state direction:
- "Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification," Journal of Biological Chemistry. Host returned client_error. Likely tier A1.
- "Fasting up-regulates muscle glutamine synthetase while it down-regulates liver glutamine synthetase in male rats during aging," European e-Journal of Clinical Nutrition and Metabolism. Not opened. Tier A1.
Recorded as retrieval debts R29.4 and R29.5. If these hold, the muscle arm of this node under fasting runs OPPOSITE to glutaminolysis, which matters for how the node is described on a customer-facing surface.
Open questions, node 29
- No human fasting measurement of GLS, GLS2, SLC1A5 or GLUD1 was located. The node's named components are unmeasured.
- The magnitude and time course of the glutamine and glutamate fall during the 10-day fast (Steinhauser 2018) is unread.
- Nurjhan 1995 subject number and fasting duration are unread.
- Whether renal glutamine gluconeogenesis rises in absolute terms during prolonged fasting, as opposed to rising as a share, was not established by any source opened.
← 28. Glycolysis All 41 nodes 30. Serine–glycine / one-carbon (folate) metabolism →
dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.